China raises $290 million for AI drug discovery startup
Anew Labs, a ByteDance spin-off, raises $290 million to develop AI-driven drugs.
Published 5j1 sourceNotable
Lire en français
≈ 18s
The fact
This funding is part of a wave of investments in Chinese biotech startups.
Investors are betting on local competitors to Anthropic and Isomorphic Labs.
Click the link to read an article on the topic: